Januvia Lawsuit News (3/29/12): Patients who use the type 2 diabetes medication Januvia (sitagliptin) may be more likely to report pancreatitis and pancreatic cancer according to a new study. This recent study was published in the July 2011 issue of Gastroenterology and research is based on the FDA’s reported adverse events. Have you developed pancreatitis after taking Januvia? You can speak with a representative from Best Legal Source to discuss the steps involved in finding a Januvia Lawyer. Best Legal Source works to connect victims with attorneys like a Januvia Lawyer who can reveal potential legal options.
A Januvia Lawsuit can cover the costs of litigation and assist you in obtaining compensation. Those who hold particular interest to a Januvia Lawsuit are consumers who developed pancreatitis or pancreatic cancer. The study reveals that patients taking Januvia have reported pancreatitis 6 fold more frequently than those taking other therapies. The findings also suggest an increased rate of 2.7-fold reports of pancreatic cancer.
Januvia Lawsuit and Januvia Lawsuit are terms used in a general sense and should not be taken to mean that Best Legal Source is the manufacturer of Januvia. For clarification purposes: the term Januvia Lawsuit is used to describe a legal professional who pursues cases involving the brand Januvia.
From the study: “[Our analysis] suggests that the [glucagon-like peptide 1 (GLP-1)] class of drugs being widely promoted for treatment of type 2 diabetes could have serious unintended and unpredicted side effects,” the authors write.
Don’t let your health fall victim to these unintended and unpredicted side effects. Call Best Legal Source today to gain representation from a knowledgeable Januvia Lawyer. Best Legal Source can find the right Januvia Lawyer for your potential case. Message us through the form above or by calling (800) 611-7080.
More study results that could potentially lead a Januvia Lawsuit to file lawsuits:
“In conclusion, the analysis of the FDA adverse event reporting database suggests that the GLP-1 class of drugs being widely promoted for treatment of type 2 diabetes could have serious unintended and unpredicted side effects. Pancreatitis is >6-fold more likely to be reported in association with sitagliptin (Januvia) or exenatide (Byetta) than other therapy in type 2 diabetes. Despite the fact that exenatide and sitagliptin have been available for a relatively short period, it is of concern that, when taken together, there is a significantly increased association of thyroid cancer and pancreatic cancer with these therapies. The most obvious conclusion from these studies is that careful long-term monitoring of patients treated with GLP-1 mimetics or DPP-4 inhibitors is required.”
Januvia Lawsuit News – 4/10/2012:
Did you take Januvia? Please contact us today if you took Januvia and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Januvia Lawsuit: Cancer wreaks havoc in almost every part of the human body. Tumors strike the brain and the gut, muscles and bones. Some grow slowly; others are more aggressive and expand quickly. Their presence in human tissues signals chaos and a breakdown of normal function. Cancer brings unwelcome change to a biological machine that is perfect, marvelously beautiful, and complex beyond measure. Wherever tumors appear, they take on the appearance of alien life forms, invaders that enter the body through stealth and begin their programs of destruction from within. But appearances deceive: The truth is much more subtle and endlessly interesting.
Tumors are not foreign invaders. They arise from the same material used by the body to construct its own tissues. Tumors use the same components—human cells-—to form the jumbled masses that disrupt biological order and function and, if left unchecked, to bring the whole complex, life- sustaining edifice that is the human body crashing down. How are human tissues put together from single cells? The description above might suggest the involvement of master builders who oversee crews of workers, directing them in the detailed construction of normal and malignant tissues. In reality, there are no overseers forcing throngs of cells to line up and assemble themselves into normal or cancerous tissues. Architectural complexity in living tissue comes from the bricks themselves, the individual cells. Control is exercised from the bottom up.
Normal and malignant cells know how to build. Each carries its own agenda that tells it when it should grow and divide and how it should aggregate with other cells to create organs and tissues. Our bodies are nothing more than highly complex societies of rather autonomous cells, each retaining many of the attributes of a fully independent organism. Right there, we confront great beauty and profound danger. The beauty lies in the coordinated behavior of so many cells to create the single, highly functional cooperative that is the human body. The danger lies in the absence of a single overseeing master builder, which seems to put the whole enterprise at great risk. Granting autonomy to trillions of worker cells invites chaos. When, as usually happens, these cells are well behaved and public-spirited, extraordinarily complex order ensues. But on occasion, a cell may choose to go its own way and invent its own novel version of a tissue or organ. It is then that we see the much-feared chaos that we call cancer.
Januvia Lawsuit News: More information about your search
Januvia Lawsuit: Most human tumors comprise a billion or more cells before we become aware of them. The cells within a tumor differ from their normal counterparts in many respects, exhibiting distinctive shapes, growth properties, and metabolism. The sudden appearance of such a horde of cells would seem to reflect some recent mass conversion, in which millions of normal cells enlisted overnight in the ranks of a tumor mass. Once again, appearances deceive. The creation of a tumor is an extraordinarily slow process, often extending over decades. The cells forming a tumor are all lineal descendants of a single progenitor, a distant ancestor that lived many years before the tumor mass became apparent. This founder, this renegade cell, decided to go off on its own, to begin its own growth, program within one of the body’s tissues. Thereafter, its proliferation was controlled by its own internal agenda rather than the needs of the community of cells around it.
So there were no millions of recruits, only a single one that spawned a vast horde of like-minded descendants. The billions of cells in a tumor are cast in the image of their renegade ancestor. They have no interest in the well-being of the tissue and organism around them. Like the founder cell, they have only one program in mind: more growth, more replicas of themselves, unlimited expansion. The chaos they create makes it clear how very dangerous it is to entrust each cell in the human body with its own measure of independence. Still, that is how we are put together, and how all complex, many-celled organisms have been designed for the past 600 million years. Learning this, we realize that the chaos of cancer is not a modern affliction but a risk run by all multicellular organisms, from ancient to modern. Indeed, given the trillions of cells in the human body, is it not a wonder that cancer does not erupt often during our long lives?
The notion that cancer was not a random, spontaneous degeneration of the body’s tissues, but instead was actively induced, radically changed the thinking of many cancer researchers. If external agents triggered die disease, perhaps they could be identified and their mechanisms of action studied. Perhaps the entire process from the initial encounter with a cancer-causing agent to the appearance of a cancer could be uncovered. So, toward the end of the nineteenth century, scientists throughout the world tried to recreate cancer in laboratory animals—mice, rats, and rabbits. For years, all such attempts failed.
The first successes came in Japan in the first decade of die new century. Katsusaburo Yamagiwa took instruction from the far earlier studies of European chimney siveeps. Percival Pott’s initial observations of high rates of scrotal cancer in London chimney sweeps had been followed several decades later by the work of others who found that chimney sweeps on the Continent had much lower rates of this tumor. The difference seemed to be related to personal hygiene practices. The British chimney sweeps, like many of their eighteenth-century countrymen, rarely took baths, while the chimney sweeps on the Continent bathed frequendy. It seemed that creosote tars from the London flues stuck to the skin of die British sweeps and triggered cancer unless washed away quickly.
Our use of the term or terms Januvia Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Lawsuit visit our site often.